Drilldown: Medicines

None · Codeine · 1,4-Butanediol · 1B-LSD · 1cP-LSD · 1P-LSD · 1V-LSD · 2-AI · 2-FA · 2-FDCK · 2-FMA · 25B-NBOH · 25B-NBOMe · 25C-NBOH · 25C-NBOMe · 25I-NBOH · 25I-NBOMe · 25N-NBOMe · 2C-B · 2C-B-FLY

Other values:

Search

None (2) · Sernyl (human, withdrawn 1965); Sernylan (veterinary, withdrawn 1978) (1)

Amphetamine (1) · Research material (2) · Stimulant (2) · [[:Category:Anesthetics|Anesthetic (historical)]] (1) · [[:Category:Arylcyclohexylamines|Arylcyclohexylamine]] (1) · [[:Category:Dissociatives|Dissociative]] (1) · [[:Category:NMDA_receptor_antagonists|NMDA receptor antagonist]] (1) · [[:Category:Sigma-1_receptor_agonists|Sigma-1 receptor agonist]] (1)

None (1) · Alpha-methylated amphetamine analogue; norepinephrine releasing agent (1) · Monoamine releasing agent (1)

None (2) · '"`UNIQ--vote-00000063-QINU`"', '"`UNIQ--vote-00000064-QINU`"' (1)

None (2) · No current medical indication. Historical anesthetic dose 0.25 mg/kg IV (Sernyl). (1)

None (2) · Historical: Sernyl 25 mg tablets, 10 mg/mL injection (human); Sernylan 100 mg/mL injection (veterinary). Illicit: white crystalline powder, oily liquid, "dipped" cigarettes ("wet"), tablets. (1)

None (2) · N/A (no current medical indication) (1)

None (2) · IM (1) · insufflated (1) · IV (1) · Oral (1) · smoked (1)

None (2) · Smoked 2-5 min; insufflated 5-15 min; oral 30-60 min; IV / IM ~5-15 min (1)

None (2) · 4-8 hours typical; longer at high doses; residual cognitive and perceptual effects up to 48 hours (1)

None (2) · Highly variable, 7-46 hours (mean ~21 h); lipophilic deposition in fat with delayed re-release contributes to wide range'"`UNIQ--ref-00000065-QINU`"' (1)

None (2) · ~72% oral; ~85% smoked'"`UNIQ--ref-00000066-QINU`"' (1)

None (3)

None (2) · [[USLegal:DEA Schedule II|Schedule II]] controlled substance in US (rescheduled from Schedule III in 1978). No accepted medical use. UN Convention on Psychotropic Substances Schedule II internationally.'"`UNIQ--ref-00000067-QINU`"' (1)